Immunocore

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunocore and other ETFs, options, and stocks.

About IMCR

Immunocore Holdings Plc operates as a commercial-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease. Its lead product KIMMTRAK is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma, in the United States, European Union, Canada, Australia and the United Kingdom.

CEO

Bahija Jallal

CEOBahija Jallal

Employees

493

Employees493

Headquarters

Abingdon, Oxfordshire

HeadquartersAbingdon, Oxfordshire

Founded

2021

Founded2021

Employees

493

Employees493

IMCR Key Statistics

Market cap

1.51B

Market cap1.51B

Price-Earnings ratio

-29.60

Price-Earnings ratio-29.60

Dividend yield

—

Dividend yield—

Average volume

339.41K

Average volume339.41K

High today

$31.03

High today$31.03

Low today

$29.97

Low today$29.97

Open price

$30.60

Open price$30.60

Volume

251.05K

Volume251.05K

52 Week high

$62.74

52 Week high$62.74

52 Week low

$23.15

52 Week low$23.15

Analyst ratings

76%

of 17 ratings

Buy

76.5%

Hold

17.6%

Sell

5.9%